Advertisement
Screener

MANNATECH INC (MTEX) Deferred Federal Income Tax Expense (Benefit)

1.2 / 5 stars · 25/107 Roast Me

MANNATECH INC Deferred Federal Income Tax Expense (Benefit)

MANNATECH INC (MTEX) reported Deferred Federal Income Tax Expense (Benefit) of $0 for the 12-month period ending 2025-12-31, per its 10-K filed 2026-04-15.

Financial Statements › Expense Statement › Income Tax

us-gaap:DeferredFederalIncomeTaxExpenseBenefit · last filed 2026-04-15

  • MANNATECH INC deferred federal income tax expense (benefit) for fiscal 2025 was $0.00.
  • MANNATECH INC deferred federal income tax expense (benefit) for fiscal 2024 was $0.00.
  • MANNATECH INC deferred federal income tax expense (benefit) for fiscal 2023 was -$2.00K, a 100.17% decline from fiscal 2022.
  • MANNATECH INC deferred federal income tax expense (benefit) for fiscal 2022 was $1.20M.
Period endDeferred Federal Income Tax Expense (Benefit) 12 month
2025-12-31$0.00
10-K · filed 2026-04-15
2024-12-31$0.00
10-K · filed 2026-04-15
2023-12-31-$2.00K
10-K · filed 2025-03-26
2022-12-31$1.20M
10-K · filed 2024-03-28
2021-12-31-$1.18M
10-K · filed 2023-03-17
2020-12-31$0.00
10-K · filed 2022-03-15
2019-12-31$0.00
10-K · filed 2021-03-19
2018-12-31$1.07M
10-K · filed 2020-03-26
2017-12-31$1.19M
10-K · filed 2019-03-11
2016-12-31-$95.00K
10-K · filed 2018-03-26
2015-12-31$191.00K
10-K · filed 2017-03-14
2014-12-31-$1.79M
10-K · filed 2016-03-15
2013-12-31-$1.88M
10-K · filed 2015-03-10
2012-12-31$0.00
10-K · filed 2014-03-18
2011-12-31-$347.00K
10-K · filed 2013-03-28

Similar stocks

Stock NameCountryMarket CapPE Ratio
NATURAL ALTERNATIVES INTERNATIONAL INC (NAII)United States$0.011B-1.16
Synergy CHC Corp. (SNYR)United States$0.001B
Functional Brands Inc. (MEHA)United States$0.001B
FITLIFE BRANDS, INC. (FTLF)United States$0.087B16.59
Niagen Bioscience, Inc. (NAGE)United States$0.238B15.72
USANA HEALTH SCIENCES INC (USNA)United States$0.264B-17.90
Canopy Growth Corp (CGC)$0.395B
Tilray Brands, Inc. (TLRY)United States$0.554B-5.97
Cronos Group Inc. (CRON)$1.223B
Definium Therapeutics, Inc. (DFTX)United States$4.931B-17.87